Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Acta Haematol
1 Ann Hematol
2 Blood
3 Br J Haematol
1 J Immunol
1 Leuk Lymphoma
4 Leukemia

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Haematol

  1. CRISTIANO G, Nanni J, Sartor C, Parisi S, et al
    Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
    Acta Haematol. 2021 Jun 15:1-5. doi: 10.1159/000516003.
    PubMed         Abstract available

    Ann Hematol

  2. WYSOCKA-SLOWIK A, Gil L, Slebioda Z, Kregielczak A, et al
    Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation.
    Ann Hematol. 2021 Jun 12. pii: 10.1007/s00277-021-04568.
    PubMed         Abstract available


  3. KATERNDAHL CDS, Rogers ORS, Day RB, Cai MA, et al
    Tumor suppressor function of Gata2 in Acute Promyelocytic Leukemia.
    Blood. 2021 Jun 14. pii: 476182. doi: 10.1182/blood.2021011758.
    PubMed         Abstract available

    Vaccination against COVID-19: a challenge in CLL.
    Blood. 2021;137:3153-3154.

    Br J Haematol

  5. GORDON MJ, Huang J, Chan RJ, Bhargava P, et al
    Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials.
    Br J Haematol. 2021;192:720-728.
    PubMed         Abstract available

  6. WANG J
    Leukaemia blues - an unusual presentation of leukaemia cutis.
    Br J Haematol. 2021;192:676.

  7. WOUTERS Y, Nevejan L, Louwagie A, Devos H, et al
    Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene.
    Br J Haematol. 2021;192:e112-e115.

    J Immunol

  8. GUETHLEIN LA, Beyzaie N, Nemat-Gorgani N, Wang T, et al
    Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01.
    J Immunol. 2021 Jun 11. pii: jimmunol.2100119. doi: 10.4049/jimmunol.2100119.
    PubMed         Abstract available

    Leuk Lymphoma

  9. BOLUDA B, Martinez-Cuadron D, Algarra L, Cano I, et al
    Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients.
    Leuk Lymphoma. 2021 Jun 14:1-10. doi: 10.1080/10428194.2021.1938031.
    PubMed         Abstract available


  10. NISHIDA Y, Zhao R, Heese LE, Akiyama H, et al
    Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML.
    Leukemia. 2021 Jun 14. pii: 10.1038/s41375-021-01308.
    PubMed         Abstract available

  11. GREAVES M, Cazzaniga V, Ford A
    Can we prevent childhood Leukaemia?
    Leukemia. 2021;35:1258-1264.

  12. BERG JL, Perfler B, Hatzl S, Uhl B, et al
    EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
    Leukemia. 2021;35:1521-1526.

  13. LARGEAUD L, Cornillet-Lefebvre P, Hamel JF, Dumas PY, et al
    Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.
    Leukemia. 2021;35:1291-1300.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.